EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The when, what, and where of naturally-acquired microchimerism

J Lee Nelson, Nathalie C Lambert

Seminars in Immunopathology · 2025

DOI: 10.1007/s00281-024-01029-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Immunopathology, 2025. Verfasst von J Lee Nelson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington, Seattle, WA, USA. lee@fredhutch.org. Hauptthemen laut MEDLINE: Chimerism, Maternal-Fetal Exchange. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 334 Literaturangaben. Gefördert von: NHLBI NIH HHS, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Naturally acquired microchimerism (Mc) is increasingly recognized as an aspect of normal biology. Maternal-fetal bi-directional exchange during pregnancy creates a Mc legacy for the long-term in both individuals. Maternal Mc in her offspring and Mc of fetal origin in women with previous births are best studied. Other sources include from a known or vanished twin, miscarriage or pregnancy termination, older sibling, or previous maternal pregnancy loss. Mc is pleotropic and protean, present in diverse forms, and changing over time as other aspects of biology. Mc acquired from multiple sources, at different lifespan times, and taking on an array of diverse forms, creates a "forward, reverse, and horizontal inheritance" Mc landscape. Mc is found in adaptive and innate immune cells, as resident tissue-specific cells in a wide variety of human tissues, and among other forms as extracellular vesicles. HLA molecules function in a myriad of ways as key determinants for health and are of central importance in interactions between genetically disparate individuals. Studies of autoimmune disease have firmly established a primary role of HLA molecules. Studies of iatrogenic chimerism have established benefit of donor-recipient HLA-disparity against recurrent malignancy after transplantation. HLA molecules and HLA-relationships of families are therefore of particular interest in seeking to understand the role(s) of Mc at the interface of auto-immunity and healthy allo-immunity. This review will begin by providing perspective on Mc in biology followed by a primary focus on persistent Mc according to the human lifespan, in healthy individuals and with illustrative examples of autoimmune diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChimerismMaternal-Fetal ExchangeHumansPregnancyFemaleAnimalsHLA AntigensAutoimmune Diseases

Stichwörter der Autor:innen

Autoimmune diseaseHLAMicrochimerism

Substanzen

HLA Antigens

Autor:innen und Institutionen

  • Department of Medicine, University of Washington, Seattle, WA, USA. lee@fredhutch.org.
  • Translational Science and Therapeutics Fred Hutchinson Cancer Center, Seattle, USA. lee@fredhutch.org.
  • INSERM UMRs 1097 Arthrites, Microchimérisme et Inflammations (ARTHEMIS), Aix Marseille Université, Marseille, France. nathalie.lambert@inserm.fr.

Förderung

  • NHLBI NIH HHS
  • Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
  • NIAID NIH HHS
  • NINDS NIH HHS
  • Inserm Transfert
  • National Heart, Lung, and Blood Institute
  • Washington Women's Foundation

Zitieren

APA

Nelson, J. L., & Lambert, N. C. (2025). The when, what, and where of naturally-acquired microchimerism. Seminars in Immunopathology. https://doi.org/10.1007/s00281-024-01029-2

Vancouver

Nelson JL, Lambert NC. The when, what, and where of naturally-acquired microchimerism. Seminars in Immunopathology. 2025. doi:10.1007/s00281-024-01029-2

BibTeX
@article{Nelson2025,
  author = {Nelson, J Lee and Lambert, Nathalie C},
  title = {The when, what, and where of naturally-acquired microchimerism},
  journal = {Seminars in Immunopathology},
  year = {2025},
  doi = {10.1007/s00281-024-01029-2}
}
Kostenlos starten →